Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was CNY 197.59 million compared to CNY 164.65 million a year ago. Revenue was CNY 197.59 million compared to CNY 164.65 million a year ago. Net income was CNY 91.74 million compared to CNY 70.45 million a year ago. Basic earnings per share from continuing operations was CNY 0.1752 compared to CNY 0.1346 a year ago. Diluted earnings per share from continuing operations was CNY 0.1752 compared to CNY 0.1346 a year ago.